Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL502831 | 1.00 | PTGS2 (0.45) | PTGS2NPSR1CYP2D6SRCLMNA | |
| SCHEMBL93387 | 1.00 | PTGS2 (0.45) | PTGS2NPSR1CYP2D6SRCLMNA | |
| SCHEMBL28995220 | 0.98 | PTGS2 (0.44) | PTGS2NPSR1CYP2D6SRCLMNA | |
| SCHEMBL27745764 | 0.90 | TRPM8 (0.45) | LMNAALDH1A1SMN1; SMN2NPC1MAPT | |
| SCHEMBL6216112 | 0.86 | RAB9A (0.44) | ALDH1A1SMN1; SMN2TP53NPC1MAPT | |
| SCHEMBL6216109 | 0.86 | RAB9A (0.44) | ALDH1A1SMN1; SMN2TP53NPC1MAPT | |
| SCHEMBL14463144 | 0.82 | NPSR1 (0.44) | PTGS2NPSR1CYP2D6SRCLMNA | |
| SCHEMBL27567147 | 0.82 | ALDH1A1 (0.41) | PTGS2NPSR1LMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL3381199 | 0.81 | ALOX5 (0.44) | LMNAALDH1A1SMN1; SMN2KMT2AALOX5 | |
| SCHEMBL21382545 | 0.81 | KMT2A (0.44) | CYP2D6ALDH1A1NPC1MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1996 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122031763-A | Metabolizable multidirectional tensile hernia patch and preparation method thereof | 中国人民解放军总医院第四医学中心 | 2026-05-15 | — | — | CN | claimed |
| US-20260114983-A1 | BIODEGRADABLE PIEZOELECTRIC NERVE-GUIDANCE CONDUIT FOR PROMOTING REGENERATION OF SEVERED NERVE AND METHOD FOR MANUFACTURING THE SAME | UIF (UNIVERSITY INDUSTRY FOUNDATION), YONSEI UNIVERSITY (KR) | 2026-04-30 | — | — | US | claimed |
| US-20260096243-A1 | PREPARATION METHOD OF ELECTRODE GRID LINES, AND PHOTOVOLTAIC (PV) CELL | Beijing Zenithnano Technology Co., Ltd. (CN) | 2026-04-02 | — | — | US | claimed |
| US-12540161-B2 | Linkers | BICYCLETX LIMITED (GB) | 2026-02-03 | — | — | US | claimed |
| EP-4665887-A1 | PEPTIDE SELF-ASSEMBLY AS A STRATEGY FOR FACILE IMMOBILIZATION OF ENZYMES AND MICROORGANISMS ON ELECTRODES | Ramot at Tel-Aviv University Ltd. (IL) | 2025-12-24 | — | — | EP | claimed |
| US-20250369136-A1 | PEPTIDE SELF-ASSEMBLY AS A STRATEGY FOR FACILE IMMOBILIZATION OF ENZYMES AND MICROORGANISMS ON ELECTRODES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2025-12-04 | — | — | US | claimed |
| EP-4642489-A1 | CONJUGATE AND USES THEREOF | Full-Life Technologies HK Limited (HK) | 2025-11-05 | — | — | EP | claimed |
| US-20250332217-A1 | IMMUNE CHECKPOINT INHIBITOR COMBINATIONS | LYTIX BIOPHARMA AS (NO) | 2025-10-30 | — | — | US | claimed |
| EP-4637800-A1 | COMPOSITIONS COMPRISING AN ONCOLYTIC PEPTIDE AND CHITOSAN | Lytix Biopharma AS (NO) | 2025-10-29 | — | — | EP | claimed |
| EP-4637799-A1 | MEDICAL PRODUCTS CONTAINING AN AQUEOUS FORMULATION OF A PEPTIDE | Lytix Biopharma AS (NO) | 2025-10-29 | — | — | EP | claimed |
| WO-1998025965-A2 | PEPTIDES AND COMPOUNDS THAT BIND TO THE THROMBOPOIETIN RECEPTOR | GLAXO GROUP LIMITED (GB) | 1998-06-18 | — | — | WO | claimed |
| US-5665704-A | VASODILATORS, HYPOTENSIVE AGENTS; METABOLIC STABILITY | GENENTECH, INC. (US) | 1997-09-09 | — | — | US | claimed |
| EP-0771209-A2 | NOVEL PEPTIDES | Merck & Co., Inc. (a New Jersey corp.) (US) | 1997-05-07 | — | — | EP | claimed |
| WO-1997014416-A1 | CONJUGATES USEFUL IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA | MERCK & CO., INC. (US) | 1997-04-24 | — | — | WO | claimed |
| WO-1997012624-A1 | NOVEL PEPTIDES | MERCK & CO., INC. (US) | 1997-04-10 | — | — | WO | claimed |
| EP-0637958-B1 | ANTI-OBESITY DRUGS | SENYORINA LTD (IL) | 1997-04-02 | — | — | EP | claimed |
| EP-0728147-A1 | RECEPTOR SPECIFIC ATRIAL NATRIURETIC PEPTIDES | GENENTECH, INC. (US) | 1996-08-28 | — | — | EP | claimed |
| WO-1996000503-A1 | NOVEL PEPTIDES | MERCK & CO., INC. (US) | 1996-01-11 | — | — | WO | claimed |
| WO-1995013296-A1 | RECEPTOR SPECIFIC ATRIAL NATRIURETIC PEPTIDES | GENENTECH, INC. (US) | 1995-05-18 | — | — | WO | claimed |
| EP-0331404-A2 | Method for producing tropane alkaloid | SEITAIKINOU RIYOU KAGAKUHIN SHINSEIZOUGIJUTSU KENKYU KUMIAI (JP) | 1989-09-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096243-A1 | PREPARATION METHOD OF ELECTRODE GRID LINES, AND PHOTOVOLTAIC (PV) CELL | EML4, GJB2, CD4 | PTGS2 3389/4885NPSR1 4233/4885CYP2D6 4089/4885 |
| US-20260114983-A1 | BIODEGRADABLE PIEZOELECTRIC NERVE-GUIDANCE CONDUIT FOR PROMOTING REGENERATION OF SEVERED NERVE AND METHOD FOR MANUFACTURING THE SAME | NGF, GAP43, BDNF | PTGS2 1506/4885NPSR1 4287/4885CYP2D6 4233/4885 |
| US-12540161-B2 | Linkers | ADM2, CDA, DCTD | PTGS2 3540/4885NPSR1 2486/4885CYP2D6 597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.